Fennec Pharmaceuticals Initiates Rolling New Drug Application to FDA for Pedmark

Research Triangle Park, NC, December 20, 2018– Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, following a pre-submission meeting with the oncology division of the U.S. Food and Drug Administration...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news